Stepan Co (SCL) stock
SCLNYSESoap, Detergents, Cleang Preparations, Perfumes, CosmeticsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/3017% above fair value
$65.94−0.83 (-1.24%)
Close on Nov 11, 2026Market cap $1.50BP/E 347.1Yield 2.35%
Stepan EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Stepan's EPS for the twelve months ending Sep 30, 2026 was $0.19, down 90.4% year over year. For fiscal 2025 it was $2.05, down 6.8% from the year before. Over ten years it grew -4.7% a year on average. The highest annual figure on record is $6.38 in fiscal 2022.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.05 | -6.8% |
| FY2024 | Dec 31, 2024 | $2.20 | +25.7% |
| FY2023 | Dec 31, 2023 | $1.75 | -72.6% |
| FY2022 | Dec 31, 2022 | $6.38 | +7.8% |
| FY2021 | Dec 31, 2021 | $5.92 | +8.6% |
| FY2020 | Dec 31, 2020 | $5.45 | +23.3% |
| FY2019 | Dec 31, 2019 | $4.42 | -7.1% |
| FY2018 | Dec 31, 2018 | $4.76 | +10.4% |
| FY2017 | Dec 31, 2017 | $4.31 | +15.5% |
| FY2016 | Dec 31, 2016 | $3.73 | +12.3% |
| FY2015 | Dec 31, 2015 | $3.32 | +33.3% |
| FY2014 | Dec 31, 2014 | $2.49 | -21.7% |
| FY2013 | Dec 31, 2013 | $3.18 | -8.9% |
| FY2012 | Dec 31, 2012 | $3.49 | +8.7% |
| FY2011 | Dec 31, 2011 | $3.21 | +8.8% |
| FY2010 | Dec 31, 2010 | $2.95 | +1.0% |
| FY2009 | Dec 31, 2009 | $2.92 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $0.78 | +66.0% |
| Q2 FY2026 | Jun 30, 2026 | $1.00 | +100.0% |
| Q1 FY2026 | Mar 31, 2026 | -$1.81 | -310.5% |
| Q4 FY2025 | Dec 31, 2025 | $0.22 | +46.7% |
| Q3 FY2025 | Sep 30, 2025 | $0.47 | -54.4% |
| Q2 FY2025 | Jun 30, 2025 | $0.50 | +19.0% |
| Q1 FY2025 | Mar 31, 2025 | $0.86 | +41.0% |
| Q4 FY2024 | Dec 31, 2024 | $0.15 | – |
| Q3 FY2024 | Sep 30, 2024 | $1.03 | +87.3% |
| Q2 FY2024 | Jun 30, 2024 | $0.42 | -23.6% |
| Q1 FY2024 | Mar 31, 2024 | $0.61 | -12.9% |
| Q4 FY2023 | Dec 31, 2023 | -$0.05 | -110.6% |
| Q3 FY2023 | Sep 30, 2023 | $0.55 | -67.8% |
| Q2 FY2023 | Jun 30, 2023 | $0.55 | -75.7% |
| Q1 FY2023 | Mar 31, 2023 | $0.70 | -63.7% |
| Q4 FY2022 | Dec 31, 2022 | $0.47 | -35.6% |
| Q3 FY2022 | Sep 30, 2022 | $1.71 | +7.5% |
| Q2 FY2022 | Jun 30, 2022 | $2.26 | +22.2% |
| Q1 FY2022 | Mar 31, 2022 | $1.93 | +10.9% |
| Q4 FY2021 | Dec 31, 2021 | $0.73 | -43.8% |
| Q3 FY2021 | Sep 30, 2021 | $1.59 | +11.2% |
| Q2 FY2021 | Jun 30, 2021 | $1.85 | +20.1% |
| Q1 FY2021 | Mar 31, 2021 | $1.74 | +47.5% |
| Q4 FY2020 | Dec 31, 2020 | $1.30 | +36.8% |
| Q3 FY2020 | Sep 30, 2020 | $1.43 | +28.8% |
| Q2 FY2020 | Jun 30, 2020 | $1.54 | +18.5% |
| Q1 FY2020 | Mar 31, 2020 | $1.18 | +10.3% |
| Q4 FY2019 | Dec 31, 2019 | $0.95 | -7.8% |
| Q3 FY2019 | Sep 30, 2019 | $1.11 | +19.4% |
| Q2 FY2019 | Jun 30, 2019 | $1.30 | -9.7% |
| Q1 FY2019 | Mar 31, 2019 | $1.07 | -21.9% |
| Q4 FY2018 | Dec 31, 2018 | $1.03 | +145.2% |
| Q3 FY2018 | Sep 30, 2018 | $0.93 | -1.1% |
| Q2 FY2018 | Jun 30, 2018 | $1.44 | +21.0% |
| Q1 FY2018 | Mar 31, 2018 | $1.37 | 0.0% |
| Q4 FY2017 | Dec 31, 2017 | $0.42 | +16.7% |
| Q3 FY2017 | Sep 30, 2017 | $0.94 | – |
| Q2 FY2017 | Jun 30, 2017 | $1.19 | – |
| Q1 FY2017 | Mar 31, 2017 | $1.37 | – |
| Q4 FY2016 | Dec 31, 2016 | $0.36 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?